Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2144.39 | 966 / 966 | 99% | 10.62 | 523 / 527 |
brain | 98% | 1815.86 | 2586 / 2642 | 99% | 21.21 | 699 / 705 |
esophagus | 98% | 1438.72 | 1419 / 1445 | 98% | 12.24 | 180 / 183 |
lung | 100% | 6046.84 | 578 / 578 | 95% | 14.09 | 1098 / 1155 |
breast | 100% | 2434.60 | 459 / 459 | 90% | 8.12 | 1011 / 1118 |
stomach | 89% | 1022.64 | 321 / 359 | 99% | 11.52 | 282 / 286 |
thymus | 99% | 1764.35 | 648 / 653 | 88% | 21.11 | 534 / 605 |
bladder | 90% | 1286.57 | 19 / 21 | 86% | 8.39 | 431 / 504 |
kidney | 74% | 861.78 | 66 / 89 | 85% | 9.34 | 763 / 901 |
uterus | 81% | 750.11 | 138 / 170 | 71% | 5.65 | 328 / 459 |
adrenal gland | 100% | 4346.12 | 258 / 258 | 47% | 5.29 | 109 / 230 |
skin | 74% | 1214.58 | 1331 / 1809 | 58% | 4.98 | 272 / 472 |
prostate | 92% | 1069.03 | 226 / 245 | 25% | 1.08 | 124 / 502 |
pancreas | 20% | 146.07 | 65 / 328 | 93% | 9.75 | 166 / 178 |
adipose | 100% | 2878.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 6089.86 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 8590.15 | 927 / 929 | 0% | 0 | 0 / 0 |
ovary | 41% | 364.87 | 74 / 180 | 55% | 2.86 | 238 / 430 |
heart | 91% | 1491.45 | 787 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 12.80 | 26 / 29 |
blood vessel | 88% | 1371.45 | 1171 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 6.34 | 39 / 45 |
liver | 27% | 214.83 | 61 / 226 | 23% | 2.08 | 94 / 406 |
muscle | 10% | 64.22 | 83 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0005634 | Cellular component | nucleus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005001 | Molecular function | transmembrane receptor protein tyrosine phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRE |
Protein name | Protein tyrosine phosphatase receptor type E PTPRE Tyrosine phosphatase epsilon PD1 Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) |
Synonyms | |
Description | FUNCTION: Isoform 1 plays a critical role in signaling transduction pathways and phosphoprotein network topology in red blood cells. May play a role in osteoclast formation and function (By similarity). .; FUNCTION: Isoform 2 acts as a negative regulator of insulin receptor (IR) signaling in skeletal muscle. Regulates insulin-induced tyrosine phosphorylation of insulin receptor (IR) and insulin receptor substrate 1 (IRS-1), phosphorylation of protein kinase B and glycogen synthase kinase-3 and insulin induced stimulation of glucose uptake (By similarity). .; FUNCTION: Isoform 1 and isoform 2 act as a negative regulator of FceRI-mediated signal transduction leading to cytokine production and degranulation, most likely by acting at the level of SYK to affect downstream events such as phosphorylation of SLP76 and LAT and mobilization of Ca(2+). . |
Accessions | S4R2Y5 ENST00000471218.5 Q5VWH5 ENST00000467366.1 ENST00000495530.5 ENST00000455661.5 ENST00000254667.8 [P23469-1] ENST00000442830.5 Q8TE48 Q96P81 ENST00000479896.1 P23469 Q5VWH6 ENST00000306042.9 [P23469-2] S4R3X3 S4R448 S4R3B0 |